The acquisition of Bayer Healthcare's diagnostic division by
Siemens Medical Solutions has been completed. Bayer Diagnostics and
Diagnostic Products Corporation (DPC), acquired in July 2006, were
merged into a single business unit on January 1, 2007. The new entity,
"Siemens Medical Solutions Diagnostics," is a wholly owned subsidiary
of Siemens Medical Solutions USA, Inc. and employs more than 8,000
people worldwide. Siemens Medical Solutions Diagnostics, headquartered
in Tarrytown, NY and Los Angeles, CA, holds a No. 2 position in the
worldwide immunodiagnostics market.
This new business is integral to Siemens' overall strategy to help
its customers improve workflow throughout the healthcare enterprise.
Bringing together the entire medical imaging, laboratory diagnostics
and clinical IT value chain under one roof puts Siemens in a unique
position to leverage trendsetting technologies for an improved quality
of patient care at reduced costs. DPC and Bayer Diagnostics generated
cumulative sales of EUR 1.8 billion in fiscal 2005 (Dec. 31). The cost
for both acquisitions totaled EUR 5.7 billion.
March 13, 2026 
